[O-06] 一般演題口演セッション06

[O-06-5] gMG患者におけるエフガルチギモドの長期安全性及び有効性:ADAPT-SC+試験の中間報告

鵜沢 顕之¹, Howard, Jr James F², Li George³, Vu Vuan⁴, Margania Temur⁵, Korobko Denis⁶, Smilowski Marek⁷, Banaszkiewicz Krzysztof⁸, Liu Li⁹, Steeland Sophie⁹, Noukens Jan¹⁰, Van Hoorick Benjamin⁹, Podhorna Jana⁹, Li Yuebing¹¹, 槍沢 公明¹², Sacca Francesco¹³, Wiendl Heinz¹⁴, De Bleecker Jan¹⁵, Mantegazza Renato¹⁶ (1.千葉大学医学部附属病院 脳神経内科, 2.The University of North Carolina, 3.Medsol Clinical Research Center Inc, 4.University of South Florida Morsani College of Medicine, 5.New Hospitals, 6.State Budgetary Healthcare Institution of Novosibirsk Region "State Novosibirsk Regional Clinical Hospital", 7.Medical University of Silesia, 8.Krakowski Szpital Specjalistyczny im. Jana Pawla II, 9.argenx, 10.Curare Consulting BV, 11.Cleveland Clinic, 12.総合花巻病院　脳神経内科, 13.Federico II University of Naples, 14.University of Munster, 15.Ghent University Hospital, 16.Fondazione Istituto Neurologico Carlo Besta)